MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis.
暂无分享,去创建一个
Helene Ratiney | Daniel Pelletier | Sarah J Nelson | S. Nelson | D. Pelletier | R. Srinivasan | H. Ratiney | Radhika Srinivasan | Kathyrn E Hammond-Rosenbluth
[1] J. Laranjinha,et al. Glutamate induces release of glutathione from cultured rat astrocytes – a possible neuroprotective mechanism? , 2008, Journal of neurochemistry.
[2] Richard B. Thompson,et al. Strongly coupled versus uncoupled spin response to radio frequency interference effects: application to glutamate and glutamine in spectroscopic imaging , 2008, NMR in biomedicine.
[3] P. E. Morris,et al. Water proton T1 measurements in brain tissue at 7, 3, and 1.5T using IR-EPI, IR-TSE, and MPRAGE: results and optimization , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.
[4] Esin Ozturk-Isik,et al. 3D 1H MRSI of brain tumors at 3.0 tesla using an eight‐channel phased‐array head coil , 2007, Journal of magnetic resonance imaging : JMRI.
[5] R. Bartha,et al. Quantitative short echo‐time 1H LASER‐CSI in human brain at 4 T , 2006, NMR in biomedicine.
[6] B. Mueller,et al. Signal‐to‐noise ratio and spectral linewidth improvements between 1.5 and 7 Tesla in proton echo‐planar spectroscopic imaging , 2006, Magnetic resonance in medicine.
[7] Alan J. Thompson,et al. Localization of grey matter atrophy in early RRMS , 2006, Journal of Neurology.
[8] Daniel B. Vigneron,et al. TE-Averaged two-dimensional proton spectroscopic imaging of glutamate at 3 T , 2006, NeuroImage.
[9] Napapon Sailasuta,et al. A comparative study of myo-inositol quantification using LCmodel at 1.5 T and 3.0 T with 3 D 1H proton spectroscopic imaging of the human brain. , 2004, Magnetic resonance imaging.
[10] L. Griffiths,et al. Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis. , 2003, Brain research. Molecular brain research.
[11] Rolf Gruetter,et al. Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference‐edited spectra , 2003, Magnetic resonance in medicine.
[12] J. Hirrlinger,et al. Glutathione Pathways in the Brain , 2003, Biological chemistry.
[13] A. Mohamed,et al. Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor. , 2003, Biomedical sciences instrumentation.
[14] Stephen M Smith,et al. Fast robust automated brain extraction , 2002, Human brain mapping.
[15] A J Thompson,et al. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.
[16] L DelaBarre,et al. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. , 2001, Journal of magnetic resonance.
[17] S. Nelson. Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors , 2001, Magnetic resonance in medicine.
[18] Stephen M. Smith,et al. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.
[19] J. Hayes,et al. Glutathione S-Transferase Polymorphisms and Their Biological Consequences , 2000, Pharmacology.
[20] S. Croul,et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis , 2000, Journal of the Neurological Sciences.
[21] A. Fryer,et al. Glutathione S-transferase polymorphisms in MS , 2000, Neurology.
[22] P. Boesiger,et al. SENSE: Sensitivity encoding for fast MRI , 1999, Magnetic resonance in medicine.
[23] M. Senda,et al. Evaluation of glutathione localization in brain using 99mTc meso-HMPAO. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] F. Barkhof,et al. Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.
[25] J. Kurhanewicz,et al. Improved water and lipid suppression for 3D PRESS CSI using rf band selective inversion with gradient dephasing (basing) , 1997, Magnetic resonance in medicine.
[26] Jullie W Pan,et al. Quantitative 1H spectroscopic imaging of human brain at 4.1 T using image segmentation , 1996, Magnetic resonance in medicine.
[27] P Wach,et al. Imaging of the active B1 field in vivo , 1996, Magnetic resonance in medicine.
[28] E. Bongarzone,et al. Oxidative damage to proteins and lipids of CNS myelin produced by in vitro generated reactive oxygen species , 1995, Journal of neuroscience research.
[29] L. Ignarro,et al. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. , 1993, Journal of immunology.
[30] R. Edelman,et al. Magnetic resonance imaging (2) , 1993, The New England journal of medicine.
[31] D. van Ormondt,et al. SVD-based quantification of magnetic resonance signals , 1992 .
[32] J. Pauly,et al. Parameter relations for the Shinnar-Le Roux selective excitation pulse design algorithm [NMR imaging]. , 1991, IEEE transactions on medical imaging.
[33] Chrit T. W. Moonen,et al. Highly Effective Water Suppression for in vivo proton NMR Spectroscopy (DRYSTEAM) , 1990 .